FR3132023B1 - PROTECTIVE INGREDIENT FOR THE SKIN AND/OR MUCOSA AGAINST VIRULENCE FACTORS - Google Patents

PROTECTIVE INGREDIENT FOR THE SKIN AND/OR MUCOSA AGAINST VIRULENCE FACTORS Download PDF

Info

Publication number
FR3132023B1
FR3132023B1 FR2200627A FR2200627A FR3132023B1 FR 3132023 B1 FR3132023 B1 FR 3132023B1 FR 2200627 A FR2200627 A FR 2200627A FR 2200627 A FR2200627 A FR 2200627A FR 3132023 B1 FR3132023 B1 FR 3132023B1
Authority
FR
France
Prior art keywords
derivatives
salts
skin
virulence factors
protective ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2200627A
Other languages
French (fr)
Other versions
FR3132023A1 (en
Inventor
Valérie Andre
Isabelle Bonnet
Manon Gault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS filed Critical BASF Beauty Care Solutions France SAS
Priority to FR2200627A priority Critical patent/FR3132023B1/en
Priority to PCT/FR2023/050094 priority patent/WO2023144487A1/en
Publication of FR3132023A1 publication Critical patent/FR3132023A1/en
Application granted granted Critical
Publication of FR3132023B1 publication Critical patent/FR3132023B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/733Alginic acid; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

INGREDIENT PROTECTEUR DE LA PEAU ET/OU DES MUQUEUSES CONTRE LES FACTEURS DE VIRULENCE La présente invention concerne une nouvelle combinaison comprenant du pullulan ou un de ses dérivés, un polysaccharide choisi parmi l’acide hyaluronique, un de ses sels ou dérivés, l’acide alginique, un de ses sels ou dérivés ou leur mélange, de l’acide succinique, un de ses sels ou dérivés, de l’acide lactique, un de ses sels ou dérivés et du sucrose, un de ses sels ou dérivé, particulièrement utile pour prévenir et/ou diminuer la virulence de C. acnes.PROTECTIVE INGREDIENT FOR THE SKIN AND/OR MUCOSA AGAINST VIRULENCE FACTORS The present invention relates to a new combination comprising pullulan or one of its derivatives, a polysaccharide chosen from hyaluronic acid, one of its salts or derivatives, the acid alginic, one of its salts or derivatives or their mixture, succinic acid, one of its salts or derivatives, lactic acid, one of its salts or derivatives and sucrose, one of its salts or derivative, particularly useful to prevent and/or reduce the virulence of C. acnes.

FR2200627A 2022-01-25 2022-01-25 PROTECTIVE INGREDIENT FOR THE SKIN AND/OR MUCOSA AGAINST VIRULENCE FACTORS Active FR3132023B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR2200627A FR3132023B1 (en) 2022-01-25 2022-01-25 PROTECTIVE INGREDIENT FOR THE SKIN AND/OR MUCOSA AGAINST VIRULENCE FACTORS
PCT/FR2023/050094 WO2023144487A1 (en) 2022-01-25 2023-01-24 Ingredient for protecting the skin and/or mucous membranes from virulence factors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2200627A FR3132023B1 (en) 2022-01-25 2022-01-25 PROTECTIVE INGREDIENT FOR THE SKIN AND/OR MUCOSA AGAINST VIRULENCE FACTORS
FR2200627 2022-01-25

Publications (2)

Publication Number Publication Date
FR3132023A1 FR3132023A1 (en) 2023-07-28
FR3132023B1 true FR3132023B1 (en) 2024-01-05

Family

ID=81325006

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2200627A Active FR3132023B1 (en) 2022-01-25 2022-01-25 PROTECTIVE INGREDIENT FOR THE SKIN AND/OR MUCOSA AGAINST VIRULENCE FACTORS

Country Status (2)

Country Link
FR (1) FR3132023B1 (en)
WO (1) WO2023144487A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009541372A (en) 2006-06-28 2009-11-26 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ Cosmetic and medical compositions comprising a plurality of hyaluronic acid fractions
FR2994387B1 (en) 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas COSMETIC OR PHARMACEUTICAL MOISTURIZING INGREDIENT
FR3064473B1 (en) * 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas PROTECTIVE INGREDIENT OF THE BALANCE OF SKIN AND / OR MUCOSAL MICROBIAL FLORA
US10675234B1 (en) * 2019-02-22 2020-06-09 N.V. Perricone Llc Systems and methods for treating and/or preventing acne

Also Published As

Publication number Publication date
WO2023144487A1 (en) 2023-08-03
FR3132023A1 (en) 2023-07-28

Similar Documents

Publication Publication Date Title
US11400106B2 (en) Methods for inhibiting microbe growth
CY1115001T1 (en) NEW PHYNYLIMIDAZOLINE PRODUCERS AS PDE10A ENZYMES INHIBITORS
MX2023007192A (en) Prmts inhibitors.
MA42811B1 (en) Monosubstituted or disubstituted indole derivatives used as inhibitors of dengue virus replication
MA35012B1 (en) PHYTOSANITARY COMPOSITION COMPRISING ESSENTIAL OILS ENHANCING ANTI-FUNGIC ACTIVITY
AU2020281332A8 (en) Dna-dependent protein kinase inhibitor
CL2023001461A1 (en) Tricyclic carboxamide derivatives as prmt5 inhibitors
WO2021168483A3 (en) Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
MA35411B1 (en) New therapeutic composition containing apomorphine as active ingredient
MX2023009222A (en) Tricyclic-amido-bicyclic prmt5 inhibitors.
MX2023003627A (en) 1,2,3,4-tetrahydroquinoline derivatives as inhibitors of the yap/taz-tead activation for treating cancer.
MX2023007476A (en) Tetrahydroquinoline derivative and medicinal use thereof.
EA202190586A1 (en) N-SUBSTITUTED DIOXOCYCLOBUTENYLAMINO-3-HYDROXIPICOLINAMIDES ACCEPTED AS CCR6 INHIBITORS
BR112022006572A2 (en) COMPLEMENT FACTOR D ORAL INHIBITORS
BR112021019817A2 (en) Pyrrole compounds
FR3132023B1 (en) PROTECTIVE INGREDIENT FOR THE SKIN AND/OR MUCOSA AGAINST VIRULENCE FACTORS
WO2022192594A3 (en) Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
Seferyan et al. Multicationic Quaternary Ammonium Compounds: A Framework for Combating Bacterial Resistance
EP4316504A3 (en) Compounds
MX2022007171A (en) Cyclic compounds and methods of using same.
EA201070898A1 (en) NEW HINAZOLIN-2,4-DIONA DERIVATIVE AND MEDICINAL COMPOSITIONS ON ITS BASIS FOR PREVENTION AND TREATMENT OF THE DISEASE, CAUSED BY DAMAGE OF THE CRANIAL NERVE
BR112023001325A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR TREATING A DISEASE CAUSED BY A VIRUS, FOR INHIBIT CAPSULE DEPENDENT ENDONUCLEASE, FOR TREAT INFLUENZA IN A MAMMAL, AND FOR PREVENTING INFLUENZA IN A MAMMAL
MX2023000198A (en) Atr inhibitors and uses thereof.
MX2022013890A (en) Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof.
BR112022019226A2 (en) RADIOIMMUNOCONJUGATES TARGETED TO FGFR3 AND USES THEREOF

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20230728

PLFP Fee payment

Year of fee payment: 3